ICAD
ICAD Inc
Price:  
1.58 
USD
Volume:  
63,954.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-206.4%
Upside

As of 2024-05-27, the EV/EBITDA ratio of ICAD Inc (ICAD) is -4.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 21.38 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.69 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.4x - 17.7x 11.0x
Forward P/E multiples 10.1x - 21.1x 16.6x
Fair Price (1.02) - (2.38) (1.68)
Upside -164.8% - -250.6% -206.4%
1.58 USD
Stock Price
(1.68) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 -4.56
2024-05-23 -4.73
2024-05-22 -4.67
2024-05-21 -4.84
2024-05-20 -4.90
2024-05-17 -5.51
2024-05-16 -5.63
2024-05-15 -4.84
2024-05-14 -4.56
2024-05-13 -4.45
2024-05-10 -4.17
2024-05-09 -3.88
2024-05-08 -3.77
2024-05-07 -3.60
2024-05-06 -3.72
2024-05-03 -3.94
2024-05-02 -4.05
2024-05-01 -3.72
2024-04-30 -3.72
2024-04-29 -4.00
2024-04-26 -3.94
2024-04-25 -4.00
2024-04-24 -4.45
2024-04-23 -4.45
2024-04-22 -4.22
2024-04-19 -4.33
2024-04-18 -4.61
2024-04-17 -4.45
2024-04-16 -4.67
2024-04-15 -4.84
2024-04-12 -5.18
2024-04-11 -5.23
2024-04-10 -5.29
2024-04-09 -5.80
2024-04-08 -4.84
2024-04-05 -4.73
2024-04-04 -4.84
2024-04-03 -6.36
2024-04-02 -4.67
2024-04-01 -4.22
2024-03-28 -4.73
2024-03-27 -4.67
2024-03-26 -4.53
2024-03-25 -4.39
2024-03-22 -4.67
2024-03-21 -4.67
2024-03-20 -4.39
2024-03-19 -4.17
2024-03-18 -4.05
2024-03-15 -4.61